Zacks Investment Research
10 Jul 2026, 22:51 UTC · 2h ago
Medtronic (MDT) Exceeds Market Returns: Some Facts to Consider
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
10 Jul 2026, 22:51 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
Medtronic is currently assigned a Zacks Rank of #4 (Sell). — A 'Sell' rating from a quantitative model with a historical track record suggests negative near-term price momentum.
-0.60Medtronic is projected to report a quarterly EPS of $1.39 and revenue of $9.48 billion, representing year-over-year increases of 10.32% and 10.53% respectively. — Strong double-digit projected growth in both top and bottom lines is a positive fundamental catalyst.
+0.40Medtronic's forward P/E ratio of 13.87 is at a discount compared to the industry average of 18. — Trading at a discount to peers suggests the stock may be undervalued, providing a potential cushion or attraction for value buyers.
+0.30Continue reading
6 related stories
Top 3 movers · tap to explore
Medtronic shares rose 1.8% in the most recent trading session, outperforming the S&P 500's 0.42% gain. — Short-term price outperformance indicates positive immediate sentiment, though it is a lagging indicator.
+0.10Which stocks this story touches
The stock outperformed the S&P 500 in the recent session and has positive forecasted revenue and EPS growth, although it holds a Zacks Rank of #4 (Sell).
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
1h ago
